Union Bancaire Privee UBP SA Buys New Holdings in Colgate-Palmolive (NYSE:CL)

Union Bancaire Privee UBP SA acquired a new stake in shares of Colgate-Palmolive (NYSE:CL) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 350 shares of the company’s stock, valued at approximately $32,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. State Street Corp increased its stake in Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after purchasing an additional 1,784,411 shares in the last quarter. Geode Capital Management LLC increased its stake in Colgate-Palmolive by 2.8% during the 3rd quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company’s stock valued at $2,095,325,000 after purchasing an additional 552,949 shares in the last quarter. Massachusetts Financial Services Co. MA increased its position in shares of Colgate-Palmolive by 6.2% during the third quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock worth $988,997,000 after acquiring an additional 557,492 shares in the last quarter. Barclays PLC increased its position in shares of Colgate-Palmolive by 38.7% during the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after acquiring an additional 2,132,747 shares in the last quarter. Finally, FMR LLC increased its position in shares of Colgate-Palmolive by 65.6% during the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock worth $700,642,000 after acquiring an additional 2,674,807 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 2.5 %

CL stock opened at $92.36 on Wednesday. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The company has a market capitalization of $74.95 billion, a price-to-earnings ratio of 26.24, a PEG ratio of 4.20 and a beta of 0.44. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The stock has a fifty day moving average of $88.86 and a 200-day moving average of $95.66.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the firm posted $0.87 earnings per share. As a group, equities research analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.17%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 56.82%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on CL. Piper Sandler decreased their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. Stifel Nicolaus decreased their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. JPMorgan Chase & Co. reduced their target price on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. Finally, UBS Group reduced their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive has an average rating of “Hold” and an average price target of $101.16.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.